Fernández-Luna, CarmenBaena, JavierCalles, AntonioAntoñanzas-Basa, MónicaLage Alfranca, YolandaMielgo, XabierSereno, MariaCervera, RaquelCabezon-Gutierrez, LuisLópez, AnaRubio, JuditConde, EstherLopez-Rios, FernandoAlvarez-Vallina, LuisValencia, KarmeleMontuenga, Luis M.Ruiz De Garibay, GorkaMolero, MagdalenaAdradas, VeraCurto-Aguilera, DanielPeressini, MelinaCarrera-Elvira, EstherBallesteros, DanielPortillo-Fernández, AdriánLopez-Cárdenas, TeresaSerrano-Gómez, CristinaBote, HelenaTorres-Jiménez, JavierCruz-Bermúdez, AlbertoProvencio, MarianoPaz-Ares, LuisSánchez-Herrero, EstelaZugazagoitia, Jon2026-09-302026-09-302026-09-10Fernández-Luna, C, Baena, J, Calles, A, Antoñanzas-Basa, M, Lage Alfranca, Y, Mielgo, X, Sereno, M, Cervera, R, Cabezon-Gutierrez, L, López, A, Rubio, J, Conde, E, Lopez-Rios, F, Alvarez-Vallina, L, Valencia, K, Montuenga, L M, Ruiz De Garibay, G, Molero, M, Adradas, V, Curto-Aguilera, D, Peressini, M, Carrera-Elvira, E, Ballesteros, D, Portillo-Fernández, A, Lopez-Cárdenas, T, Serrano-Gómez, C, Bote, H, Torres-Jiménez, J, Cruz-Bermúdez, A, Provencio, M, Paz-Ares, L, Sánchez-Herrero, E & Zugazagoitia, J 2026, 'Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer', Journal for immunotherapy of cancer, vol. 14, no. 9, e016133. https://doi.org/10.1136/jitc-2026-0161332051-1426PubMedCentral: PMC13583861https://hdl.handle.net/10641/8369Publisher Copyright: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.135155787enghttp://creativecommons.org/licenses/by-nc-nd/4.0/Lung CancerNeoadjuvantTumor Microenvironmentco-stimulatory moleculesImmunology and AllergyImmunologyMolecular MedicineOncologyPharmacologyCancer ResearchSDG 3 - Good Health and Well-beingYesjournal articleopen access10.1136/jitc-2026-016133https://www.scopus.com/pages/publications/105050273925https://www.scopus.com/pages/publications/105050273925#tab=citedBy